Delivery Order SPE2DB22D2211-SPE2DB25FSDHY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $35,990.01. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30, with a contract ceiling value of $4,134.12. This is a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ondansetron ODT 4 mg tablets in a 30-count quantity, with a ceiling value of $4,245.12. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation and is scheduled for ultimate completion by July 28, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ondansetron ODT 4 mg tablets in a 30-count quantity. This firm fixed-price delivery order, valued at $7,580.15, represents a competitively awarded non-set-aside contract with an ultimate completion date of August 29, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $2,291.00 and an ultimate completion date of June 17, 2025. The contract carries no set-aside designation, indicating it was awarded through competitive procurement. Performance will be executed from AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $4,445.95 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT (orally disintegrating tablet) 4 mg tablets in quantities of 30, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price contract reflects a non-set-aside procurement and represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with DLA. The contract specifies performance at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $18,470.50 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count packaging). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $3,686.07. This competitively awarded, firm fixed-price delivery order represents a continuation of the contractor's critical role in supporting federal pharmaceutical procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count packaging) with a ceiling value of $5,868.57 and a firm fixed price structure. The contract is classified as a non-set-aside, competitively awarded delivery order with an ultimate completion date of July 30, 2025. The pharmaceutical products will be supplied from AmerisourceBergen's Conshohocken, Pennsylvania location, which serves as the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) with a firm fixed price ceiling value of $11,979.29. The contract, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-competitive, non-set-aside delivery order. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDHYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Ondansetron ODT (orally disintegrating tablet) 4 mg tablets in a 30-count quantity, with a ceiling value of $3,978.32. This is a firm fixed price delivery order with an ultimate completion date of August 22, 2025, and represents a non-competitive set-aside contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally, enabling the delivery of a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp fulfills pharmaceutical procurement needs for military and veteran healthcare systems, including support to the Defense Health Agency and U.S. Coast Guard through competitively awarded delivery orders with consistent firm fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/21/25 |